Practice Pearls

What can we help you find?
Future Implications of Subcutaneous Dosing
Concluding the discussion, the panel considers future directions for subcutaneous dosing.
Financial Benefit of Subcutaneous Dosing
Experts move on to discuss the various levels of financial benefit with subcutaneous dosing.
Calculating Dose for SQ Formulations
Practical considerations regarding the dosing of subcutaneous formulations
Pharmacokinetic Differences with SQ Dosing
Key opinion leaders break down the pharmacokinetic properties of subcutaneous formulations.
Adding SQ Dosing to the Formulary
Experts discuss who and what is involved in adding subcutaneous formulations to the formulary.
Benefits of SQ Dosing for Patients
A panel of experts reviews the benefits of subcutaneous dosing from the patient perspective.
Selecting SQ Formulation for a Patient
Factors that inform the decision to stratify patients to subcutaneous formulations.
Addressing Reluctance to Use SQ Dosing
Potential clinical and financial causes for hesitation in the transition to subcutaneous dosing are addressed.
Educating Staff on SQ Dosing
Experts provide perspective on how they prepare their staff for the transition to subcutaneous dosing.
Impact of Subcutaneous Dosing Preparation
The differences in subcutaneous formulation preparation and the corresponding impact on practice.
The Benefits of a Flat Dose
Experts consider the reasoning behind flat dosing of subcutaneous formulations, as well as its added benefit.
A discussion on the role of payers in the oral oncolytic dispensing process.